EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Mechanism, Dose, and Administration of Dexmedetomidine in Managing Visceral Pain Associated With Surgery: A Narrative Review

Ruonan Tian, Zongming Jiang, Han Zhou, Yunzhi Wang

Medical Science Monitor · 2026

DOI: 10.12659/msm.950564 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Science Monitor, 2026. Verfasst von Ruonan Tian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shaoxing University School of Medicine, Shaoxing, Zhejiang, China. Hauptthemen laut MEDLINE: Dexmedetomidine, Visceral Pain. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Visceral pain is often refractory and debilitating. Effective therapy for visceral pain remains undetermined or even elusive. Recently, dexmedetomidine (DEX) has been found to be promising as an adjuvant in relieving visceral pain. DEX, a highly selective alpha-2 adrenoreceptor agonist, is increasingly used during the perioperative period. DEX induces sedation, analgesia, anxiolysis, sympathetic tone inhibition, and intestinal barrier protection. It has shown favorable analgesic effects in clinical and animal studies and is a useful adjuvant treatment for visceral pain. It can be delivered via intravenous injections, intraspinal administration, intraperitoneal spraying, or other routes, and it exerts antinociceptive effects on visceral pain. This article reviews the mechanisms, dose, and modes of administration of dexmedetomidine in managing visceral pain associated with surgery. Moreover, we highlight the clinical evidence of DEX on visceral pain therapy in recent years. We also address the various protocols and routes for using DEX in the treatment of visceral pain, aiming to provide a foundation and direction for clinical practice and basic research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidineVisceral PainHumansAnimalsPostoperative PainAnalgesics, Non-NarcoticAdrenergic alpha-2 Receptor AgonistsPain ManagementAnalgesics

Substanzen

DexmedetomidineAnalgesics, Non-NarcoticAdrenergic alpha-2 Receptor AgonistsAnalgesics

Autor:innen und Institutionen

  • Shaoxing University School of Medicine, Shaoxing, Zhejiang, China.
  • Department of Anesthesiology and Perioperative Medicine, Shaoxing People's Hospital, The First Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, China.

Zitieren

APA

Tian, R., Jiang, Z., Zhou, H., & Wang, Y. (2026). Mechanism, Dose, and Administration of Dexmedetomidine in Managing Visceral Pain Associated With Surgery: A Narrative Review. Medical Science Monitor. https://doi.org/10.12659/msm.950564

Vancouver

Tian R, Jiang Z, Zhou H, Wang Y. Mechanism, Dose, and Administration of Dexmedetomidine in Managing Visceral Pain Associated With Surgery: A Narrative Review. Medical Science Monitor. 2026. doi:10.12659/msm.950564

BibTeX
@article{Tian2026,
  author = {Tian, Ruonan and Jiang, Zongming and Zhou, Han and Wang, Yunzhi},
  title = {Mechanism, Dose, and Administration of Dexmedetomidine in Managing Visceral Pain Associated With Surgery: A Narrative Review},
  journal = {Medical Science Monitor},
  year = {2026},
  doi = {10.12659/msm.950564}
}
Kostenlos starten →